147 related articles for article (PubMed ID: 5486142)
21. [Effect of cholinergic-blocking agents on the fibrinolytic system of blood in patients with ulcer disease].
Lapchinskiĭ ID
Vrach Delo; 1975 Aug; (8):76-81. PubMed ID: 1221615
[No Abstract] [Full Text] [Related]
22. [Observations on the use of an new pharmacologic association with anticholinergic-sedative action (oxyphencyclimine-promazine)].
Mioli V
G Clin Med; 1965 Jan; 46(1):54-72. PubMed ID: 5892935
[No Abstract] [Full Text] [Related]
23. [Effect of several adrenomimetic and adrenoblocking substances on the secretory activity of the stomach].
Fisher AA; Berlizova LK
Ter Arkh; 1972 Mar; 44(3):78-81. PubMed ID: 5027957
[No Abstract] [Full Text] [Related]
24. [Lysozyme concentration in the gastric juice in peptic ulcer].
Lobanova ND; Rudyk BI
Antibiotiki; 1980 Jan; 25(1):48-51. PubMed ID: 7356301
[TBL] [Abstract][Full Text] [Related]
25. [Therapeutic effect of a new antisecretory and anti-acid drug].
Galli L; Bissi A
Rev Bras Gastroenterol; 1967; 19(3):43-9. PubMed ID: 4387428
[No Abstract] [Full Text] [Related]
26. The assessment of the antipeptic effect of ulcer therapy.
Massewitsch C; Gorschkow W
Acta Hepatogastroenterol (Stuttg); 1977 Dec; 24(6):452-5. PubMed ID: 602622
[TBL] [Abstract][Full Text] [Related]
27. [Clinical study on the use of phentonium in hypersecretive and ulcerative gastroduodenal diseases].
Azzollini F; Fichera G
Clin Ter; 1972 Nov; 63(3):259-67. PubMed ID: 4644530
[No Abstract] [Full Text] [Related]
28. [The anti-cholinergic treatment of peptic ulcer].
Levy N
Harefuah; 1971 Oct; 81(7):340-1. PubMed ID: 5141714
[No Abstract] [Full Text] [Related]
29. [Therapeutic effectiveness of metamizil in peptic ulcer].
Samoed VS
Vrach Delo; 1965 Aug; 8():29-33. PubMed ID: 5870988
[No Abstract] [Full Text] [Related]
30. [Clinical trial of a new synthetic anticholinergic: 1290 CERM].
Herne N; Parneix Y
Mars Med; 1969; 106(7):628-30. PubMed ID: 5399370
[No Abstract] [Full Text] [Related]
31. [The use of dipheridin in duodenal peptic ulcer].
Karapetian GN; Grebenev AL; Kolosova OL
Klin Med (Mosk); 1966 Apr; 44(4):91-3. PubMed ID: 5987729
[No Abstract] [Full Text] [Related]
32. [Effect of drug substances on the blood flow in the gastric mucosa in peptic ulcer].
Malov IuS
Voen Med Zh; 1980 Jan; (1):57-9. PubMed ID: 7376498
[No Abstract] [Full Text] [Related]
33. [Clinical pharmacology of the stomach and its radiotelemetric study].
Fishzon-Ryss IuI; Timakov VA
Klin Med (Mosk); 1967 May; 45(5):136-41. PubMed ID: 5607511
[No Abstract] [Full Text] [Related]
34. [Evaluation of the relationship between the basal gastric secretion and observed after histamine administration].
Soltysiak A; Dziewaltowska D; Alichniewicz A
Pol Tyg Lek; 1969 Jul; 24(29):1116-8. PubMed ID: 5808599
[No Abstract] [Full Text] [Related]
35. Effect of parapenzolate bromide (Relanol) on the gastric acid secretion of patients with peptic ulceration.
Fung WP
Aust N Z J Med; 1972 Feb; 2(1):37-8. PubMed ID: 4502716
[No Abstract] [Full Text] [Related]
36. [Value of ranitidine in gastroduodenal ulcer].
Buligescu L; Milcu V; Voiculescu M; Sava C; Popescu A; Dumitrescu D; Stefănescu D
Rev Med Interna Neurol Psihiatr Neurochir Dermatovenerol Med Interna; 1985; 37(4):357-60. PubMed ID: 2865797
[No Abstract] [Full Text] [Related]
37. [Use of metacin and dimecoline in the complex therapy of patients with peptic ulcer].
Landa VZ; Reĭngardt BK; Starostenko LN
Vrach Delo; 1971 Mar; 3():69-72. PubMed ID: 4397059
[No Abstract] [Full Text] [Related]
38. [Effect of metamizil on the capillary system of patients with ulcer diseases].
Samoed VS
Vrach Delo; 1965 Oct; 10():148-9. PubMed ID: 5873553
[No Abstract] [Full Text] [Related]
39. New therapeutic agents for peptic ulcer.
Augur NA
J Maine Med Assoc; 1971 Oct; 62(10):245-6 passim. PubMed ID: 4937792
[No Abstract] [Full Text] [Related]
40. [Pentagastrin as a stimulant of maximum gastric secretion in man].
Laudano OM
Rev Esp Enferm Apar Dig; 1968 Apr; 27(4):544-9. PubMed ID: 5670665
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
